Infectious Disease Update for Consultant Pharmacists

This course is approved by the Florida Board of Pharmacy for 4 consultant recertification hours.

Program Details

  • Intended Audience:  Pharmacists interested in Infectious Disease
  • Universal Activity Number: 0012-0000-22-0XX-H99-P
  • Contact Hours: 4.0 Consultant Recertification/General
  • Program Fees: $60
  • Dates Available: 07/01/2022-07/01/2025
  • Activity Type: Knowledge


Residential care facilities vary widely in purpose from long term care facilities for the aged, to psychiatric centers, to rehab facilities, to the prison system.  All of these types of patient care arenas have specific needs based on population and most common therapeutic needs upon which the focus most of their effort.  With this in mind often the treatment of infectious diseases is complicated by these environments and lack of specialization by the primary care providers in those arenas.  Pharmacists can provide guidance in these situations to help fill the knowledge gap and help provide the care of patients in these settings.


At the completion of this activity, the participant will be able to:

  • Identify the primary concerns for the spread of tuberculosis in a resident population
  • Describe the current treatment plan for tuberculosis
  • Assess the treatment needs for decubitus ulcers
  • Describe steps in the prevention and treatment of pneumococcal disease
  • Recommend alternative drugs when faced with resistant organisms
  • Describe the current therapeutics treatments for Hepatitis A and B
  • Detail the steps necessary when dealing with a Rotavirus/Norovirus outbreak
  • Describe the latest therapeutic choices for the treatment of HIV
  • Detail the latest vaccine schedule recommendations that would apply to the typical populations of residential care facilities.
  • Review the epidemiology of TB in the US based on the 2021 CDC data
  • Describe the emerging treatments for LTBI and for active disease.
  • Evaluate treatment regimens for infected decubitus ulcers
  • Discuss the treatment of pneumococcal disease
  • Describe the place in therapy of new antimicrobials
  • Recommend therapeutic options for multidrug-resistant Gram-negative organisms
  • Describe the current treatments and management for Hepatitis A and B
  • Detail the steps necessary when dealing with a Rotavirus/Norovirus outbreak
  • Describe the latest therapeutic choices for the treatment of HIV
  • Describe the current common vaccinations necessary for residential care facilities
  • Detail the CDC/ACIP process for review of the adult schedule
  • Describe some of the latest changes regarding vaccinations that might affect residential care patients
Woman in mask

Disclosure Statement

The following speakers, reviewers, and planning committee members have disclosed that he/she has no relevant financial disclosures. No one else in a position to control content has any financial relationships to disclose.

Lindsey Childs-Kean
Department: Pharmacotherapy & Translational Research

Lindsey Childs-Kean Pharm.D., M.P.H., BCPS

Clinical Associate Professor
Randell E Doty
Department: Pharmacotherapy & Translational Research

Randell E Doty Pharm.D.

Clinical Associate Professor
Charles Peloquin
Department: Pharmacotherapy & Translational Research

Charles Peloquin Pharm.D.

Professor And The Jack C. Massey Professor; Division Head, Translational Research
Barbara Santevecchi
Department: Pharmacotherapy & Translational Research

Barbara Santevecchi Pharm.D., BCPS, BCIDP

Clinical Assistant Professor

Schedule of Activities and Requirements for Successful Course Completion

Review the course material, receive a 70% or higher on the post-test, and submit a course evaluation.

Additional Resources

Please review the resources below before registering for the course.

ACPE logo

The University of Florida College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.